Gastric Adenocarcinoma, Oesophageal Carcinoma
Conditions
Brief summary
This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.
Detailed description
Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors. We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.
Interventions
OTHERQuestionnaire
Auto and hetero questionnaires: * STAI Y B, State-Trait Anxiety Inventoriage * Brief COPE * RHHI-24, Revised Health Hardiness Inventory * IPQ-R, Illness Perception Questionnaire
Sponsors
University of Lille Nord de France
University Hospital, Lille
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* age ≥ 18 years * oesophageal, oeso-gastric junction or gastric cancer non treated cancer * patient informed of his diagnosis * speak fluent french
Exclusion criteria
* history of cancer * psychological history * patient under guardianship- * fortuitous diagnosis of cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time limit of first doctor consultation | baseline | Median time between date of symptoms appearance and date of first consultation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| cTNM Stage | baseline | Stage TNM by distinguishing the early stages (I, II) vs. (III, IV) |
| clinical variables (i.e medical history, symptoms, entry into care pathway) | baseline | clinical variables associated with time of first doctor consultation |
| Time limit of system of care | baseline | Median time between date of he beginning of clinical investigations and the beginning of treatment |
| Emotional variables | baseline | Emotional variables associated with time of first doctor consultation |
| Survival | At 3 years | — |
| Socio-cognitive variables | baseline | Socio-cognitive variables associated with time of first doctor consultation |
Countries
France
Outcome results
None listed